Pulmonary Mucormycosis With Cavitatory Lung Involvement: A Fatal Case Despite Combined Therapy

Technical Summary: Pulmonary Mucormycosis With Cavitatory Lung Involvement

Problem Statement
Pulmonary mucormycosis is a rare, life-threatening fungal infection typically associated with hematological malignancies and solid organ transplants. In patients with uncontrolled diabetes mellitus, the infection predominantly manifests as rhino-cerebral mucormycosis, making pulmonary involvement in this demographic uncommon and often overlooked. The diagnosis is frequently delayed due to clinical and radiological overlaps with pulmonary tuberculosis, other bacterial pneumonias, and malignancies. This delay is critical, as early initiation of antifungal therapy and surgical intervention are the primary determinants of survival. The paper addresses the diagnostic challenges and poor prognosis associated with pulmonary mucormycosis in a patient with uncontrolled diabetes, specifically highlighting a case where combined medical and surgical therapy failed to prevent mortality.

Methodology
This study presents a single-case report of a 55-year-old female with a 15-year history of uncontrolled diabetes mellitus. The patient presented with hemoptysis, fever, weight loss, and cough. The diagnostic workflow included:

• Clinical and Laboratory Assessment: Evaluation of vital signs, inflammatory markers (CRP, ESR, Procalcitonin), and metabolic profiles (HbA1c, blood glucose). Initial sputum tests for Mycobacterium tuberculosis (acid-fast bacilli and Xpert Ultra) and bacterial cultures were negative.
• Radiological Imaging: Initial chest radiography revealed right upper zone consolidation and a cavity. Subsequent contrast-enhanced computed tomography (CECT) identified a cavitary lesion with surrounding ground-glass opacities and a "bird's-nest" appearance (thin bands within the cavity).
• Histopathological and Microbiological Analysis: CT-guided true-cut biopsy and bronchoscopy with transbronchial lung biopsy were performed. Histology (H&E stain) revealed broad, irregular, non-septate fungal hyphae consistent with the order Mucorales. Direct fungal microscopy and cultures (sputum and bronchial wash) were negative.
• Therapeutic Intervention: The patient was treated with intravenous liposomal amphotericin B (L-AmB) at 5 mg/kg/day. Glycemic control was managed, and renal/electrolyte side effects (hypokalemia, hypomagnesemia) were treated with supportive care.
• Surgical Management: Due to persistent fungal hyphae on repeat biopsy and incomplete resolution of the lesion after 40 days of medical therapy, a right upper lobectomy was performed by a multidisciplinary team.

Key Results

• Diagnosis: The patient was confirmed to have pulmonary mucormycosis via histopathology (H&E morphology favoring Mucorales), despite negative fungal cultures. The specific species could not be identified.
• Clinical Course: Following the initiation of L-AmB, the patient's fever subsided, CRP levels decreased, and glycemic control improved. However, the cavitary lesion showed only partial reduction in size (from 5.3 cm to 3.3 cm) over 40 days, and repeat biopsy remained positive for fungal hyphae.
• Outcome: Post-lobectomy, the patient developed septicemia and multiorgan failure, leading to death on postoperative day five.
• Radiological Findings: The case highlighted the "bird's-nest sign" (cavitary lesion with thin internal bands) in the context of uncontrolled diabetes, a feature suggestive of invasive fungal infection when correlated with clinical context.

Key Contributions

• Clinical Presentation in Diabetes: The report documents a rare presentation of pulmonary mucormycosis in a patient with uncontrolled diabetes, a demographic where rhino-cerebral involvement is the norm. It emphasizes that pulmonary involvement should be considered even in the absence of rhino-cerebral symptoms.
• Radiological Significance: The paper identifies the "bird's-nest sign" on CT as a significant radiological indicator for pulmonary mucormycosis in the appropriate clinical setting, distinguishing it from other conditions like tuberculosis or aspergillosis.
• Diagnostic Challenges: The case underscores the difficulty in isolating the organism via culture, noting that histopathology is often the definitive diagnostic tool when cultures are negative.
• Treatment Limitations: Despite aggressive combined therapy (high-dose liposomal amphotericin B and surgical resection), the patient succumbed to the disease, reinforcing the high mortality rate (up to 87% in pulmonary cases) associated with this infection.

Significance and Claims
The authors claim that this case highlights the critical necessity for early identification and diagnosis of pulmonary mucormycosis, particularly in patients with poorly controlled diabetes, even when the presentation mimics more common conditions like tuberculosis. The paper asserts that:

1. Early Intervention is Mandatory: The delay in initiating antifungal therapy until a histological diagnosis was confirmed was a major prognostic factor.
2. Combined Therapy is Preferred but Not Guaranteed: While the combination of medical and surgical management is the preferred mode of treatment and associated with higher survival rates, the outcome in this case demonstrates that it does not guarantee survival, especially when diagnosis is delayed.
3. Contextual Diagnosis: In patients with uncontrolled diabetes, pulmonary mucormycosis must be considered a differential diagnosis for cavitary lung lesions, and the "bird's-nest sign" should trigger a high index of suspicion.

The paper concludes that while the incidence of mucormycosis is rising globally and in Sri Lanka, the burden of healthcare costs and the challenge of early diagnosis remain significant barriers to improving survival rates.